logo-loader
LON:TRX

Tissue Regenix Group PLC

Recieve alerts
Market:
LON
Market Cap:
£45.71 m
Price
0.00
Change
0%
52 weeks high
9.75
52 weeks low
3.10
;

In brief

TISSUE REGENIX GROUP is a pioneering, international medical technology company, focusing on the development of regenerative products utilising our two platform technologies, dCELL®, addressing soft tissue needs, and BioRinseTM, providing inductive bone allografts.

We are helping to transform the treatment of patients in three key areas: BioSurgery, Orthopaedics & Dental and Cardiac.